<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00874627</url>
  </required_header>
  <id_info>
    <org_study_id>K070602</org_study_id>
    <nct_id>NCT00874627</nct_id>
  </id_info>
  <brief_title>Sublingual Milk Immunotherapy in Children</brief_title>
  <acronym>Lactaide</acronym>
  <official_title>Sublingual Milk Immunotherapy in Children With IgE-mediated Cow Milk Protein Allergy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ESPCI Paris</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sublingual immunotherapy is developing in the treatment of aeroallergens allergy. The&#xD;
      hypothesis is that such process may be applied to food allergy, more precisely to milk. A&#xD;
      previous series of 8 patients indicates the likely effectiveness of this technique (Allergy,&#xD;
      2006).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      National study of current practice, multicentric, randomized, open All oral provocation tests&#xD;
      will be randomized, double blind Study treatment. For oral provocation test, placebo with&#xD;
      NeocatePasteurized half skimmed milk (available in standard outlets) from 0.1 to 0.8 mL/day&#xD;
      Tests At M0 :1) Clinical examination 2) Biological test (blood sample 16.5 mL) : WBC,&#xD;
      ferritin, total IgE, specific IgE, cow milk, ALPHALACTALBUMIN , casein, BETALACTOGLOBULIN and&#xD;
      goat milk using RASTSpecific secretory IgA by ESPCI (frozen saliva)Biologic collection-&#xD;
      Specific immunoglobulins against cow' milk, ALPHALACTALBUMIN, casein, BETALACTOGLOBULIN,&#xD;
      quantification of IgM, sub classes of IgG and IgA by ESPCI (frozen serum).&#xD;
&#xD;
      Analysis of minor allergens by immunoblot 2 D, ESPCI (frozen serum)3) prick tests 4) 1 or 2&#xD;
      oral provocation test (TPO) double blind, during 2 days At M3 : clinical examination, side&#xD;
      effects during the 3 preceding months At M6 :1) Clinical examination 2) Biological test&#xD;
      (blood sample 16.5 mL) : WBC, ferritin, total IgE, specific IgE, cow milk, ALPHALACTALBUMIN,&#xD;
      casein, BETALACTOGLOBULIN and goat milk using RAST Specific secretory IgA by ESPCI (frozen&#xD;
      saliva)Biologic collection Specific immunoglobulins against cow' milk, ALPHALACTALBUMIN,&#xD;
      casein, BETALACTOGLOBULIN, quantification of IgM, sub classes of IgG and IgA by ESPCI (frozen&#xD;
      serum).&#xD;
&#xD;
      Analysis of minor allergens by immunoblot 2 D, ESPCI (frozen serum)3) prick tests 4) 1 or 2&#xD;
      oral provocation test (TPO) double blind, during 2 days At M12 :1) Clinical examination2)&#xD;
      Biological test (blood sample 16.5 mL) : WBC, ferritin, total IgE, specific IgE, cow milk,&#xD;
      ALPHALACTALBUMIN, casein, BETALACTOGLOBULIN and goat milk using RAST Specific secretory IgA&#xD;
      by ESPCI (frozen saliva)Biologic collection- Specific immunoglobulins against cow' milk,&#xD;
      ALPHALACTALBUMIN, casein, BETALACTOGLOBULIN , quantification of IgM, sub classes of IgG and&#xD;
      IgA by ESPCI (frozen serum).&#xD;
&#xD;
      Analysis of minor allergens by immunoblot 2 D, ESPCI (frozen serum)3) prick tests 4) 1 or 2&#xD;
      oral provocation test (TPO) double blind, during 2 days&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2008</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">September 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reactive milk dose at inclusion, at 6 months and at 12 months</measure>
    <time_frame>at inclusion, at 6 months and at 12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Skin reaction at inclusion at 6 months and at 12 months</measure>
    <time_frame>at inclusion at 6 months and at 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Specific IgE rate at inclusion, at 6 months and at 12 months</measure>
    <time_frame>at inclusion, at 6 months and at 12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">51</enrollment>
  <condition>Cow Milk Allergy</condition>
  <arm_group>
    <arm_group_label>Experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Administration of Milk</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>meals without milk</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Milk</intervention_name>
    <description>sublingual administration of milk</description>
    <arm_group_label>Experimental</arm_group_label>
    <other_name>sublingual administration of milk</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Milk</intervention_name>
    <description>placebo</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Children, male and female&#xD;
&#xD;
          -  Children &gt; 5 years&#xD;
&#xD;
          -  Children with IgE-mediated cow milk allergy, with detectable specific IgE (&gt; 0.10&#xD;
             KU/l) and an immediate type reaction during oral provocation test for a cumulated dose&#xD;
             &lt; 100 mL of milk).&#xD;
&#xD;
          -  Children and parents or tutors having given their informed consent after complete&#xD;
             information&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Children participating or having already participated to a drug trial during the 3&#xD;
             preceding months&#xD;
&#xD;
          -  Children with immune deficiency&#xD;
&#xD;
          -  Children with disabling disease, preventing from a correct practice of sublingual&#xD;
             treatment&#xD;
&#xD;
          -  Children receiving steroid therapy&#xD;
&#xD;
          -  Children refusing to participateSevere food neophobia&#xD;
&#xD;
          -  Reaction to placebo during the double blind oral provocation test&#xD;
&#xD;
          -  Severe anaphylactic reaction with milk during the 6 preceding months&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christophe Dupont, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Cochin - Saint-Vincent de Paul</name>
      <address>
        <city>Paris</city>
        <zip>75679</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2012</verification_date>
  <study_first_submitted>April 1, 2009</study_first_submitted>
  <study_first_submitted_qc>April 1, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 2, 2009</study_first_posted>
  <last_update_submitted>December 10, 2012</last_update_submitted>
  <last_update_submitted_qc>December 10, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 11, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>children &gt; 5 years old</keyword>
  <keyword>IgE-mediated</keyword>
  <keyword>cow milk allergy</keyword>
  <keyword>IgE-mediated cow milk allergy persisting after 5 years</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypersensitivity</mesh_term>
    <mesh_term>Milk Hypersensitivity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

